Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanTransplantation, HomologousTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeRemission InductionStem CellsSalvage TherapyDisease-Free SurvivalEtoposideHodgkin DiseaseMyeloablative AgonistsLymphoma, Non-HodgkinCyclophosphamideRecurrenceCytarabineCarmustineHematopoietic Stem Cell MobilizationGraft vs Host DiseaseBone Marrow TransplantationSurvival RateThiotepaVincristineBone Marrow PurgingHematologic NeoplasmsSurvival AnalysisLymphoma, Mantle-CellWhole-Body IrradiationAmyloidosisRetrospective StudiesHematopoietic Stem CellsBusulfanBoronic AcidsDexamethasonePyrazinesGraft SurvivalDoxorubicinPrognosisAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularAutograftsAntigens, CD34Follow-Up StudiesLymphoma, T-Cell, PeripheralAntineoplastic Agents, AlkylatingLiver TransplantationThalidomideIfosfamideMesenchymal Stem Cell TransplantationLeukapheresisPrednisoneInduction ChemotherapyTime FactorsGranulocyte Colony-Stimulating FactorPodophyllotoxinLymphomaAntineoplastic AgentsTransplantation ChimeraLymphoma, Large B-Cell, DiffuseNeoplasm, ResidualMaintenance ChemotherapyTissue DonorsCord Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteCell TransplantationKidney TransplantationEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsLymphoma, B-CellMyelodysplastic SyndromesIdarubicinInfusions, SpinalLeukemia, Plasma CellMitoxantroneNeoplasms, Second PrimaryAdult Stem CellsBlood Component RemovalImmunosuppressive AgentsHistocompatibility TestingProspective StudiesCarboplatinAntibodies, MonoclonalFeasibility StudiesKeratins, Type IICell DifferentiationLeukemia, MyeloidNeoplasm Recurrence, LocalFatal OutcomeHistocompatibilityMesenchymal Stromal CellsLife TablesCisplatinRadioimmunotherapyHematopoiesis